Cargando…
The STELVIO trial, a game changer for bronchoscopic lung volume reduction in patients with severe emphysema
The STELVIO trial was crucial to ensure that bronchoscopic lung volume reduction using one-way valves has evolved from an experimental intervention into a state-of-the-art treatment option for specific patients with advanced emphysema http://bit.ly/2IgMrsp
Autores principales: | Posthuma, Rein, Vanfleteren, Lowie E.G.W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7078737/ https://www.ncbi.nlm.nih.gov/pubmed/32194773 http://dx.doi.org/10.1183/20734735.0004-2020 |
Ejemplares similares
-
Effects of a comprehensive, inpatient pulmonary rehabilitation programme in a cachectic patient with very severe COPD and chronic respiratory failure
por: Franssen, Frits M.E., et al.
Publicado: (2019) -
Increased exercise tolerance using daytime mouthpiece ventilation for patients with diaphragm paralysis
por: Koopman, Maud, et al.
Publicado: (2017) -
Preview of Sleep and Breathing Conference 2019 and report on Early Career Member international collaboration
por: De Brandt, Jana, et al.
Publicado: (2019) -
Lung volume reduction for severe emphysema: scalpel or bronchoscope?
por: Gesierich, Wolfgang, et al.
Publicado: (2023) -
Patient Selection for Bronchoscopic Lung Volume Reduction
por: Welling, Jorrit B A, et al.
Publicado: (2020)